CClinicalTrials.gg
CompletedNCT01084616Updated Dec 17, 2010

Vaginal Microbiota Among Postmenopausal Women

An observational study in Vulvovaginal Atrophy, sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's. Completed at 1 site in Canada. Open to female participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2010-12-17.

Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
16
Ages
30 Years to 80 Years
Sex
Female
01

Study summary

It is known that vaginal bacteria have an impact upon the health status of the host, in some cases protecting against infection and in other cases causing infection, depending on the bacterial types present. This study will compare the composition of vaginal bacteria to symptoms of vaginal dryness in order to try and identify if certain bacteria might cause some of the problems associated with vaginal dryness among post-menopausal women.

02

Conditions studied

  • Vulvovaginal Atrophy

Browse trials for

03

In context

Atrophy

828 studies on the registry are indexed under Atrophy; 122 are open to participants now.

This study's enrollment of 16 is below the median of 85 across 199 observational studies indexed under Atrophy.

Browse Atrophy studies →

Lead sponsor

London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's is the lead sponsor of 352 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Postmenopausal women

Eligibility criteria

Inclusion Criteria:

  • Between 30 and 80 years old.
  • Postmenopausal = 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels > 40 mIU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy.
  • Prepared not to take hormone replacement therapy during 8 weeks follow-up and not taking estrogen alone or estrogen/progestin containing drug products at the time of screening.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
16 participants (actual)

Groups and cohorts

  • Vaginal Dryness
  • Non-vaginal dryness
06

Study locations

1 site
  • Victoria Family Medical Center
    London, Ontario ON N5Z, Canada
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01084616
Lead sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
First posted
Mar 10, 2010
Start date
Jan 2010
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Dec 17, 2010

Study contacts

Gregor Reid, PhD
principal investigator · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion